Form 4 for GPCR Structure Therapeutics Inc.

Accepted 2026-04-23 16:21:05 ET · period of report 2026-04-15 · accession 0001712069-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-04-23 16:21	2026-04-15	GPCR	Lang Matthew	COO, GC	A - Grant	$0.00	+184.6K	184.6K	New	$0
D	2026-04-23 16:21	2026-04-15	GPCR	Lang Matthew	COO, GC	A - Grant	$0.00	+223.8K	223.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-04-15	A	A	184,614	$0.00	184,614	D	—	—	(F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. (F2) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of April 15, 2026, subject to Reporting Person's continued service on such dates.
2	Derivative	Share option (right to buy)	2026-04-15	A	A	223,776	$0.00	223,776	D	$18.08 · — to 2036-04-14	223,776 Ordinary Shares	(F3) The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. (F4) One-fourth of the shares vest on the first anniversary of April 15, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.